Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

synthetic human papillomavirus 16 E6 peptide

A synthetic peptide sequence of human papillomavirus (HPV) type 16 oncoprotein E6. The E6 oncoprotein is implicated in the tumorigenesis of cervical carcinoma. Vaccination with HPV 16 E6 peptide may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against cells expressing the E6 oncoprotein, resulting in tumor cell lysis.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	HPV-16 E6 HPV-16 E6 peptide HPV16 E6 human papillomavirus 16 E6 peptide

synthetic human papillomavirus 16 E6 peptide

Search NCI's Drug Dictionary